glutathione stransferase antioxidant Mitochondrial GSH redox cycle and interaction with other Impact of Oxidative Changes and

101 SuzukiH.MuramatsuM.KojimaT.TakiW

10.1016/j.pestbp.2022.105137 276 YoungS

We are performing a thorough biochemical and structural characterization of the corresponding recombinant proteins, before deciphering the biological roles of the most promising candidates using genetic approaches

PMID: 39922420 Int Immunopharmacol Hesperetin alleviates PM2.5-induced lung injury by inhibiting ferroptosis in an Nrf2-dependent manner

While results are required to be submitted no later than 12 months after the Primary Completion Date, Collins notes for certain applicable clinical trials, the period is up to three years. If the drug or biologic was not approved, licensed, or cleared by the FDA, the results may not be due at all

Individuals recovering from illness or immune suppression